About
ATLASense is addressing healthcare’s most significant and growing challenge: transitioning care from hospitals to homes safely and cost-effectively while preventing life-threatening events. Introducing REPHAEL: the world’s first wearable platform delivering ICU-level monitoring and predictive insights anywhere—hospital, home, or on the go. REPHAEL isn’t just a monitor; it PREDICTS, detects, and alerts healthcare teams to critical risks like respiratory failure, sepsis, heart failure, and falls—days before they escalate. By enabling SAFE, informed clinical decisions remotely ensure hospital-level care at home.
REPHAEL allows ICU-Grade Precision: Continuous, comprehensive monitoring powered by proprietary sensors and AI-driven insights. Its economical advantage: A reusable device that serves multiple patients with various morbidities, offering the lowest cost of use compared to any alternative. Enabling SAFE Decisions: Provides doctors with actionable, predictive data.
Funding history · 3 rounds · $2.8M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is ATLASense Biomed's primary product?
- ATLASense Biomed's primary product is REPHAEL, a wearable platform designed for ICU-level monitoring and predictive insights to facilitate the transition of healthcare from hospitals to homes.
- When was ATLASense Biomed founded?
- ATLASense Biomed was founded in June 2015.
- What is the total amount of funding ATLASense Biomed has raised?
- ATLASense Biomed has raised a total of $2,810,000 USD across its funding rounds.
- What was ATLASense Biomed's most recent funding round?
- ATLASense Biomed's most recent funding round was a Seed round in August 2022, raising $1,000,000 USD.
- How many employees does ATLASense Biomed currently have?
- ATLASense Biomed currently has 12 employees.
- Where is ATLASense Biomed's headquarters located?
- ATLASense Biomed's headquarters is located in Hod HaSharon, Israel.
- Has ATLASense Biomed received any grants?
- Yes, ATLASense Biomed has received grants from the IIA, including $300,000 in December 2023, $75,000 in September 2021, and $335,000 in January 2020.
- What significant award did ATLASense Biomed receive in early 2020?
- In February and March 2020, ATLASense Biomed earned the top prize in the Henry Ford Health System's Global Health Tech Challenge for its patient monitoring system.
- What are the core technologies utilized by ATLASense Biomed's REPHAEL platform?
- The REPHAEL platform by ATLASense Biomed utilizes Artificial Intelligence, Machine Learning, Sensing, Communications, and IoT technologies.